Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00573027 · ClinicalTrials.gov registry record · NA

Heart Disease of the Small Arteries in Women and Men

A NA study of Heart Disease, sponsored by Cedars-Sinai Medical Center.

Recruiting
Registry status
NA
Development phase
634
Enrollment target
1
Study location

NCT00573027 is a NA study of Heart Disease that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 634 participants, below the 2,026-participant average among 31 other Heart Disease trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00573027, a NA study of Heart Disease, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.

RECRUITING
Registry status
NA
Development phase
634 participants
Enrollment target
1
Study location

Study Summary

Women suffer disproportionately than men from Cardiac Syndrome X ( chest pain in the absence of flow limiting coronary artery stenosis). Coronary microvascular disease is hypothesized to mediate chest pain in this syndrome. This disorder of the small heart vessels (arterioles) compared to the large vessels (arteries) is not diagnosed during routine heart catheterization. This results in delays in diagnosis, missed opportunities for treatment, and likely contributes to the increased death rate from coronary heart disease in women compared to men. Current testing for small vessel disease is performed in the cardiac catheterization laboratory using specialized testing and is not performed routinely. Accordingly, women with this condition are either falsely reassured, or misdiagnosed as another non-cardiac condition. Unnecessary healthcare costs related to re-hospitalization and repeat angiography are incurred, while women are often not initiated on appropriate lifesaving treatment. We and others have demonstrated in randomized controlled trials that therapies that target the endothelium, e.g. statins, ACE inhibitors, and exercise are effective in this condition. Majority of women with Cardiac Syndorme X go undiagnosed. Recent studies have shown significant increased health care costs, morbidity and mortality related to this disease. It is becoming more important to further characterize this group of patients and we hope to do that with our study.

Conditions Studied

Interventions

  • PROCEDURE noninvasive tests

Study Locations (1)

California

  • Cedars-Sinai Women's Heart Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 634 participants
Start Date 2005-11
Est. Completion 2040-01
Phase NA

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT00573027

The ClinicalTrials.gov registry entry for NCT00573027 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 634 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,026-participant average among 31 other Heart Disease trials with a reported enrollment target (69% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which noninvasive tests is the first listed.

NCT00573027 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00573027 about?

NCT00573027 is a clinical study titled "Heart Disease of the Small Arteries in Women and Men". Women suffer disproportionately than men from Cardiac Syndrome X ( chest pain in the absence of flow limiting coronary artery stenosis). Coronary microvascular disease is hypothesized to mediate chest pain in this syndrome. This disorder of the small heart vessels (arterioles) compared to the large ...

What is the current status of trial NCT00573027?

This trial is currently recruiting. It is a NA study. The enrollment target is 634 participants. The study started on 2005-11. Estimated completion is 2040-01.

What conditions does trial NCT00573027 study?

This clinical trial studies the following conditions: Heart Disease.

What interventions are being tested in trial NCT00573027?

The interventions under investigation include: noninvasive tests (PROCEDURE).

Who is sponsoring clinical trial NCT00573027?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00573027 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.